Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients.

[1]  A. Wree,et al.  NLRP3 inflammasome activation is required for fibrosis development in NAFLD , 2014, Journal of Molecular Medicine.

[2]  Z. Derdák,et al.  Obesity-associated mechanisms of hepatocarcinogenesis. , 2014, Metabolism: clinical and experimental.

[3]  A. Wree,et al.  NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice , 2014, Hepatology.

[4]  J. Kugler,et al.  Bariatric surgery in severely obese adolescents improves major comorbidities including hyperuricemia. , 2014, Metabolism: clinical and experimental.

[5]  T. McLaughlin,et al.  Subcutaneous Adipose Cell Size and Distribution: Relationship to Insulin Resistance and Body Fat , 2013, Obesity.

[6]  A. Kahraman,et al.  Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients. , 2013, Clinical science.

[7]  Karen R Fitzgerald.  Review of article: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 by Katherine M. Flegal, PhD; Margaret D. Carroll, MSPH; Brian K. Kit, MD; Cynthia L. Ogden, PhD (JAMA 2012;307:491-7). , 2013, Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing.

[8]  J. George,et al.  Management of nonalcoholic steatohepatitis: an evidence-based approach. , 2012, Clinics in liver disease.

[9]  M. Pollheimer,et al.  Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice , 2012, Hepatology.

[10]  Guido Gerken,et al.  The interaction of hepatic lipid and glucose metabolism in liver diseases. , 2012, Journal of hepatology.

[11]  K. Flegal,et al.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.

[12]  E. Rimm,et al.  Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease , 2011, Circulation.

[13]  A. Wree,et al.  Adipokine expression in brown and white adipocytes in response to hypoxia , 2011, Journal of Endocrinological Investigation.

[14]  K. Clément,et al.  C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients. , 2011, Journal of hepatology.

[15]  B. Neuschwander‐Tetri.  Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites , 2010, Hepatology.

[16]  L. Lynch,et al.  The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity , 2010, PloS one.

[17]  K. Petersen,et al.  Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[18]  K. Clément,et al.  Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. , 2009, Journal of hepatology.

[19]  U. Akarca,et al.  Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study , 2009, BMC gastroenterology.

[20]  Jeanne M Clark,et al.  The epidemiology of nonalcoholic fatty liver disease: a global perspective. , 2008, Seminars in liver disease.

[21]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[22]  S. Wijmenga,et al.  Structure and Dynamics of Human Apolipoprotein CIII* , 2008, Journal of Biological Chemistry.

[23]  Claude Bouchard,et al.  Effects of bariatric surgery on mortality in Swedish obese subjects. , 2007, The New England journal of medicine.

[24]  C. Herder,et al.  Relationship between adipocyte size and adipokine expression and secretion. , 2007, The Journal of clinical endocrinology and metabolism.

[25]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[26]  Björn Carlsson,et al.  The FASEB Journal • FJ Express Full-Length Article Separation of human adipocytes by size: hypertrophic fat , 2022 .

[27]  F. Pattou,et al.  The evolution of severe steatosis after bariatric surgery is related to insulin resistance. , 2006, Gastroenterology.

[28]  K. Flegal,et al.  Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.

[29]  P. Libby,et al.  Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells , 2006, Circulation.

[30]  G. Marchesini,et al.  Insulin resistance: A metabolic pathway to chronic liver disease , 2005, Hepatology.

[31]  A. Krasinskas,et al.  Surgically-Induced Weight Loss Significantly Improves Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome , 2005, Annals of Surgery.

[32]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[33]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[34]  D. Lau,et al.  Adipokines: molecular links between obesity and atheroslcerosis. , 2005, American journal of physiology. Heart and circulatory physiology.

[35]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[36]  R. Unger.  Lipid overload and overflow: metabolic trauma and the metabolic syndrome , 2003, Trends in Endocrinology & Metabolism.

[37]  D. Hadizadeh,et al.  Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome , 2003, Clinical pharmacology and therapeutics.

[38]  F. Sacks,et al.  LDL Containing Apolipoprotein CIII Is an Independent Risk Factor for Coronary Events in Diabetic Patients , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[39]  M. McCarty.  Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. , 1999, Medical hypotheses.

[40]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[41]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[42]  P. Arner,et al.  Differences at the Receptor and Postreceptor Levels Between Human Omental and Subcutaneous Adipose Tissue in the Action of Insulin on Lipolysis , 1983, Diabetes.

[43]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[44]  K. Cianflone,et al.  Changes in predicted cardiovascular disease risk after biliopancreatic diversion surgery in severely obese patients. , 2014, Metabolism: clinical and experimental.

[45]  Shiriki K. Kumanyika,et al.  Gastrointestinal surgery for severe obesity , 1991 .